Organigram Global (NASDAQ:OGI) Rating Increased to Hold at Wall Street Zen

Organigram Global (NASDAQ:OGI) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Organigram Global in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Organigram Global has an average rating of “Sell”.

Organigram Global Stock Up 17.1%

Shares of OGI stock opened at $1.92 on Friday. Organigram Global has a 52-week low of $0.85 and a 52-week high of $2.08. The stock has a market cap of $259.21 million, a PE ratio of 38.41 and a beta of 1.50. The business has a 50-day simple moving average of $1.68 and a 200-day simple moving average of $1.58.

Hedge Funds Weigh In On Organigram Global

A number of large investors have recently bought and sold shares of OGI. Baader Bank Aktiengesellschaft acquired a new stake in Organigram Global in the second quarter valued at approximately $338,000. Vontobel Holding Ltd. raised its stake in shares of Organigram Global by 140.5% during the 2nd quarter. Vontobel Holding Ltd. now owns 69,753 shares of the company’s stock worth $94,000 after buying an additional 40,753 shares during the period. Clear Harbor Asset Management LLC purchased a new position in shares of Organigram Global during the 2nd quarter valued at approximately $54,000. Cidel Asset Management Inc. grew its stake in Organigram Global by 112.3% in the 2nd quarter. Cidel Asset Management Inc. now owns 37,103 shares of the company’s stock valued at $50,000 after acquiring an additional 19,627 shares during the period. Finally, Tidal Investments LLC increased its holdings in Organigram Global by 4.9% in the 2nd quarter. Tidal Investments LLC now owns 2,646,879 shares of the company’s stock worth $3,573,000 after acquiring an additional 124,356 shares in the last quarter. Institutional investors and hedge funds own 34.63% of the company’s stock.

Organigram Global Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.